The customer complained of a questionable result for 1 patient tested for a1c-3 tina-quant hemoglobin a1c gen.3 (hba1c) on a cobas 8000 c 502 module.Two separate doctors ordered hba1c testing on the same patient so the patient had two samples drawn at the same time.For sample a the initial hba1c result was 6.7% while sample b¿s initial hba1c result was 5.8%.The sample b result of 5.8% was reported outside of the laboratory.The doctor questioned the reported hba1c result due to the differences between sample a and sample b.Sample b was retested on (b)(6) 2017 and an hba1c result of 6.8% was obtained.The retest result of sample b was deemed to be correct and a corrected report was issued.The patient was not treated based on the original result.There was no adverse event.The samples were aliquoted by a modular pre-analytics analyzer.The hba1c reagent lot was 253327 with an expiration date of 31-jan-2019.The field engineering specialist was unable to find a cause.He checked the operation of the instrument.The customer ran calibration, qc, and precision testing which all passed.
|